đź“‹ FDA Reference
polyvue 55 single vision toric and multifocal soft hydrophilic contact lens for daily wear
Polyvue Distribution
Summary: The Polyvue 55 is a soft hydrophilic contact lens for daily wear, designed for vision correction in patients with astigmatism or presbyopia. It is typically used by optometrists and ophthalmologists.
FDA Clearance Information
Pathway
510K
Number
K080794 ↗
Decision Date
December 17, 2008
Product Code
LPL
Device Class
Class 2
Evidence
419 studies
The Polyvue 55 contact lens was cleared through the FDA 510(k) pathway on December 17, 2008. Manufactured by Polyvue Distribution, it is classified as a Class 2 medical device.
What It Is
The Polyvue 55 is a soft hydrophilic contact lens available in toric and multifocal designs, intended for daily wear. It is used to correct refractive errors such as astigmatism and presbyopia, providing clear vision by focusing light directly onto the retina. The lens material allows for oxygen permeability, enhancing comfort and eye health during wear.
Clinical Applications
These lenses are commonly used in optometry and ophthalmology practices for patients requiring vision correction for astigmatism or presbyopia. They are suitable for a wide range of patients, including those who prefer the convenience of daily wear lenses. The lenses are typically fitted and prescribed during routine eye examinations.
Indications for Use
The Polyvue 55 lenses are indicated for patients with astigmatism or presbyopia who require vision correction. They are suitable for individuals seeking a comfortable and convenient daily wear lens option.
Practical Considerations
The Polyvue 55 lenses are available in various sizes to accommodate different corneal shapes and refractive needs. They are designed for compatibility with standard lens care solutions and should be fitted by a qualified eye care professional to ensure optimal performance and comfort.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is Polyvue 55 used for?
The Polyvue 55 is used for correcting vision in patients with astigmatism or presbyopia.
What specialties typically use this device?
Optometrists and ophthalmologists commonly use this device in their practice.
What are the FDA-cleared indications?
The lenses are indicated for daily wear to correct astigmatism and presbyopia.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.